SearchDictionaryMobileLogin

[Pharmacokinetic and clinical studies on cefodizime in obstetrics and gynecology]

AbstractCefodizime (CDZM), a new cephem antibiotic, was studied in terms of its pharmacokinetics and clinical efficacy in the field of obstetrics and gynecology, and the results are summarized as follows: Concentrations of CDZM in serum and genital tissues following 1 g drip infusion (30 min.) were determined and good penetration of CDZM into tissues was recognized. The maximum level in uterine arterial serum was 56.25 micrograms/ml and maximum tissue levels ranged 23.56-40.64 micrograms/g which were above its MIC80's for main pathogenic organisms. Peak concentrations of CDZM in pelvic dead space exudates following 1 g intravenous bolus injection or drip infusion ranged 6.25-6.52 micrograms/ml. The clinical efficacy of CDZM in 17 cases of obstetrical and gynecological infections was investigated using a dose of 1-3 g daily. The clinical efficacy rate was 88.2% (15/17 cases). Bacteriologically, the eradication rate was 83.3%. No side effects or abnormal laboratory test values were observed.
AuthorsN Cho, K Fukunaga, K Kunii (Affiliation: Department of Obstetrics and Gynecology, School of Medicine, Showa University.)
JournalThe Japanese journal of antibiotics (Jpn J Antibiot) Vol. 42 Issue 10 Pg. 2069-81 (Oct 1989) ISSN: 0368-2781 JAPAN
PMID2607597 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Cefotaxime
  • cefodizime
Topics
  • Adult
  • Aged
  • Bacteria (drug effects)
  • Bacterial Infections (drug therapy)
  • Cefotaxime (administration & dosage, analogs & derivatives, pharmacokinetics, pharmacology)
  • Drug Evaluation
  • Drug Resistance, Microbial
  • Female
  • Genital Diseases, Female (drug therapy)
  • Genitalia, Female (metabolism)
  • Humans
  • Infusions, Intravenous
  • Injections, Intravenous
  • Middle Aged
  • Tissue Distribution